Study of Acalabrutinib Alone or in Combination Therapy in Subjects With B-cell Non-Hodgkin Lymphoma
Clinical trial NCT02180711 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02180711
- Sponsor
- Acerta Pharma BV
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-29
- Primary completion
- 2023-08-25
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.